Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Works by Shin, Gyeongseon
Results: 13
1
2
Unveiling the Biosimilar Paradox of Oncologists' Perceptions and Hesitations in South Korea: A Web-Based Survey Study.
- Published in:
- BioDrugs, 2024, v. 38, n. 2, p. 301, doi. 10.1007/s40259-023-00640-3
- By:
- Publication type:
- Article
3
Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries.
- Published in:
- BioDrugs, 2024, v. 38, n. 1, p. 133, doi. 10.1007/s40259-023-00636-z
- By:
- Publication type:
- Article
4
HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Selftesting strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e163, doi. 10.3350/cmh.2024.1057
- By:
- Publication type:
- Article
5
Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 166, doi. 10.3350/cmh.2024.0484
- By:
- Publication type:
- Article
6
Unaware and unpowered: evaluating patient perceptions and preferences of biosimilars in South Korea.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1551451
- By:
- Publication type:
- Article
7
Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 19, p. 12366, doi. 10.3390/ijerph191912366
- By:
- Publication type:
- Article
8
The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 17, p. 11100, doi. 10.3390/ijerph191711100
- By:
- Publication type:
- Article
9
For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 7, p. 4204, doi. 10.3390/ijerph19074204
- By:
- Publication type:
- Article
10
Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 5, p. 2494, doi. 10.3390/ijerph19052494
- By:
- Publication type:
- Article
11
Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population?
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060932
- By:
- Publication type:
- Article
12
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 445, doi. 10.3390/vaccines10030445
- By:
- Publication type:
- Article
13
Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article